Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Financial Times

00:56 EST 19th January 2019 | BioPortfolio

Here are the most relevant search results for "Financial Times" found in our extensive news archives from over 250 global news sources.

More Information about Financial Times on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Financial Times for you to read. Along with our medical data and news we also list Financial Times Clinical Trials, which are updated daily. BioPortfolio also has a large database of Financial Times Companies for you to search.

Showing News Articles 1–25 of 742 from Financial Times

Friday 18th January 2019

FT Health: Fighting the three biggest infectious diseases

Guest curator Peter Sands on action against Aids, TB and malaria

Thursday 17th January 2019

Scientists ‘listen’ to light to see cancer more clearly

New technology builds on effect first observed by Alexander Bell in 1880

A lack of diversity undermines clinical trial data

Race and ethnicity vary patients’ response to drugs

Sunday 13th January 2019

Beyond ‘superbabies’: how Crispr is revolutionising medicine

Genome-editing offers new tools for diagnostics, drug discovery and treating disease

Life Biosciences joins the longevity race

US start-up looking at ways to extend life valued at $500m after funding round

Brexit brinkmanship: playing chicken over May’s deal

Failure to win Commons approval will intensify the brinkmanship that has left all sides believing they can secure their own outcome

Thursday 10th January 2019

Big pharma raises bet on biotech as frontier for growth

In the past month almost $100bn has been spent on acquisitions

Sanofi and Novo Nordisk raise US insulin prices

Cost increase for essential medicine comes as drugmakers face political pressure

Wednesday 9th January 2019

Takeda set to divest $10bn of assets after Shire deal

Japanese pharmaceutical group eyes reduction in $48bn debt pile following acquisition

Tuesday 8th January 2019

Norwegian pharma company’s oil experiment blows up

Vistin Pharma to shut energy arm after being hit by wild swings in the oil market

Monday 7th January 2019

Takeda completes £46bn acquisition of Shire

AstraZeneca hires controversial head of cancer R&D

Drugmaker ‘doubles down’ on cancer treatments and appoints José Baselga to oversee unit

AstraZeneca rejigs its research and development operations

Drugmaker ‘doubles down’ on cancer treatments and looks to speed up decision-making

Eli Lilly to buy Loxo Oncology for $8bn in cancer drug push

Thursday 3rd January 2019

Bristol-Myers/Celgene: square the circle

BMS claims acquisition will result in 40% boost to annual earnings per share

New light on photosynthesis raises green revolution hopes

Genetic breakthrough increases crop growth 40% in trials

Celgene deal a ‘catalyst’ for pharma takeovers

Bristol-Myers Squibb’s $90bn takeover sets stage for big pharma M&A in 2019

Bristol-Myers Squibb to acquire Celgene in $90bn deal

Cash and stock offer ranks as one of the biggest pharmaceutical deals in history

Bristol-Myers Squibb to acquire Celgene for $74bn

Cash and stock offer will rank as one of the biggest pharmaceutical deals in history

Wednesday 2nd January 2019

Pharma finds its feet in fight against climate change

As well as reducing emissions, the industry seeks to develop drugs as disease patterns shift

Sunday 30th December 2018

Healthy volunteers drive UK boom in infection research

New techniques make it easier for scientists to monitor immune system’s reaction to pathogens

Friday 28th December 2018

Falling vaccination rates pose a global health risk

Scepticism over immunisation has grown alongside rising populism

Longevity drugs: about time

Blue sky businesses - ageing is a better target than the diseases of age

Friday 21st December 2018

Emma Walmsley, a fast-talker shaking up GSK

The CEO has lost no time in ruthlessly reshaping the health and pharmaceuticals group

FT Health: 2018 in review

FT writers’ picks, stroke study, most-read articles


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks